Mika Hoshino

Fukushima, 9601295, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers.

Journal: Biomedicines

Published: December 22, 2022

Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer

Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 26, 2022

β-Catenin Expression in Non-Small Cell Lung Cancer and Therapeutic Effect of Immune Checkpoint Inhibitors

β-Catenin Expression in Non-Small Cell Lung Cancer and Therapeutic Effect of Immune Checkpoint Inhibitors

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: September 26, 2022

CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC.

CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC.

Journal: Anticancer research

Published: October 04, 2021

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.

The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: May 19, 2021

Monitoring Tumor Infiltrating Lymphocytes by Peripheral Blood in Lung Cancer Patients

Monitoring Tumor Infiltrating Lymphocytes by Peripheral Blood in Lung Cancer Patients

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: November 01, 2020

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004).

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 29, 2020

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden.

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden.

Journal: Oncology letters

Published: July 22, 2020

Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma.

Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma.

Journal: Oncology letters

Published: August 22, 2019

Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer.

Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: September 03, 2018

Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.

Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: February 23, 2018

Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.

Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.

Journal: Fukushima journal of medical science

Published: February 21, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026